When tumours are uncommon, decisions matter more. Expertise and collaboration turn uncertainty into strategy.
Join us at #IUCS26 & discuss with @DanieleRaggi83, Italy, in presence or virtually!
Discover more & register for free ๐งทhttps://t.co/0vxle5Vv1j
#IUCS#TesticularCancer
๐งฌ #IUCS26 Poll โ Post-chemo residual mass in NSGCT
๐จโโ๏ธ 30M with met NSGCT
๐ Complet cisplatin based chemotherapy
๐งซ Residual mass biopsy shows:
๐ฌ Teratoma with somatic transformation sarcoma
๐ญ What is the best next step?
๐ When biology changes, does surgery become the tx?
Few days to the #IUCS26 Call for Abstracts deadline!
๐๏ธDeadline: July 10
Showcase your research in urological cancers & join the 2026 programme!
๐ Awards & Travel Grants
๐ค Mini-Oral opportunities
๐ E-posters onsite
๐Submit: https://t.co/GxtM41KaY1
#IUCS#urology#cancer
๐งฌ #IUCS26 Poll โ Post EV+pembro: What drives your next move?
๐A challenging real-world scenario:
Prog after EV + pembroโฆ
โ๏ธMultiple therapeutic optionsโฆ
๐ญ So what truly guides your decision?
Join the debate with Syed A. Hussain at #IUCS26
๐ https://t.co/0vxle5Vv1j